Publication | Closed Access

Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)

InflammationEpidemiologyEquator StudyCardiovascular DiseaseMyocardial InfarctionCoronary Artery DiseaseImmunologyChronic InflammationBiomarkersInflammatory MarkerVascular BiologyPublic HealthMedicineAtherosclerosisRheumatoid ArthritisInflammatory BiomarkersCoronary Heart DiseaseHigh Risk